Cargando…

Synbiotics Alleviate the Gut Indole Load and Dysbiosis in Chronic Kidney Disease

Chronic kidney disease (CKD) has long been known to cause significant digestive tract pathology. Of note, indoxyl sulfate is a gut microbe-derived uremic toxin that accumulates in CKD patients. Nevertheless, the relationship between gut microbiota, fecal indole content, and blood indoxyl sulfate lev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Chih-Yu, Chen, Ting-Wen, Lu, Wan-Lun, Liang, Shih-Shin, Huang, Hsien-Da, Tseng, Ching-Ping, Tarng, Der-Cherng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826693/ https://www.ncbi.nlm.nih.gov/pubmed/33435396 http://dx.doi.org/10.3390/cells10010114

Ejemplares similares

Synbiotics Containing Nanoprebiotics: A Novel Therapeutic Strategy to Restore Gut Dysbiosis
por: Hong, Liang, et al.
Publicado: (2021)

Antibiotic-Therapy-Induced Gut Dysbiosis Affecting Gut Microbiota—Brain Axis and Cognition: Restoration by Intake of Probiotics and Synbiotics
por: Dahiya, Divakar, et al.
Publicado: (2023)

Gut Dysbiosis and Kidney Diseases
por: Cao, Chujin, et al.
Publicado: (2022)

Heat stress in pigs and broilers: role of gut dysbiosis in the impairment of the gut-liver axis and restoration of these effects by probiotics, prebiotics and synbiotics
por: Ringseis, Robert, et al.
Publicado: (2022)

Synbiotic Intervention Ameliorates Oxidative Stress and Gut Permeability in an In Vitro and In Vivo Model of Ethanol-Induced Intestinal Dysbiosis
por: Patel, Dhara, et al.
Publicado: (2022)

The Anti-Inflammatory, Anti-Oxidative, and Anti-Apoptotic Benefits of Stem Cells in Acute Ischemic Kidney Injury
por: Lee, Kuo-Hua, et al.
Publicado: (2019)

Trichostatin A Alleviates Renal Interstitial Fibrosis Through Modulation of the M2 Macrophage Subpopulation
por: Tseng, Wei-Cheng, et al.
Publicado: (2020)

Synbiotic (Lactiplantibacillus pentosus GSSK2 and isomalto-oligosaccharides) supplementation modulates pathophysiology and gut dysbiosis in experimental metabolic syndrome
por: Khanna, Sakshi, et al.
Publicado: (2021)

Synbiotics Supplements Lower the Risk of Hand, Foot, and Mouth Disease in Children, Potentially by Providing Resistance to Gut Microbiota Dysbiosis
por: Guo, Xiaoying, et al.
Publicado: (2021)

Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats
por: Zhao, Ze-Hua, et al.
Publicado: (2019)

The gut microbiota metabolite indole alleviates liver inflammation in mice
por: Beaumont, Martin, et al.
Publicado: (2018)

Sodium Butyrate Alleviates Mouse Colitis by Regulating Gut Microbiota Dysbiosis
por: Dou, Xiujing, et al.
Publicado: (2020)

Axl alleviates DSS-induced colitis by preventing dysbiosis of gut microbiota
por: Yee, Su-Min, et al.
Publicado: (2023)

Probiotics, Prebiotics, and Synbiotics: Gut and Beyond
por: Vyas, Usha, et al.
Publicado: (2012)

Acute Kidney Injury and Gut Dysbiosis: A Narrative Review Focus on Pathophysiology and Treatment
por: Chou, Yu-Ting, et al.
Publicado: (2022)

Gut microbe-derived metabolite indole-3-carboxaldehyde alleviates atherosclerosis
por: Lu, Yijing, et al.
Publicado: (2023)

Targeting Uremic Toxins to Prevent Peripheral Vascular Complications in Chronic Kidney Disease
por: Wu, Chia-Lin, et al.
Publicado: (2020)

Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease
por: Hung, Szu‐Chun, et al.
Publicado: (2017)

Beyond a Measure of Liver Function—Bilirubin Acts as a Potential Cardiovascular Protector in Chronic Kidney Disease Patients
por: Tsai, Ming-Tsun, et al.
Publicado: (2018)

Iron Therapy in Chronic Kidney Disease: Days of Future Past
por: Lee, Kuo-Hua, et al.
Publicado: (2021)

Impact of Gut Dysbiosis on Neurohormonal Pathways in Chronic Kidney Disease
por: Jazani, Nima H., et al.
Publicado: (2019)

Boeravinone B alleviates gut dysbiosis during myocardial infarction‐induced cardiotoxicity in rats
por: Chen, Yu, et al.
Publicado: (2021)

Tributyrin alleviates gut microbiota dysbiosis to repair intestinal damage in antibiotic-treated mice
por: Yang, Ning, et al.
Publicado: (2023)

Volume Overload and Adverse Outcomes in Chronic Kidney Disease: Clinical Observational and Animal Studies
por: Hung, Szu-Chun, et al.
Publicado: (2015)

Timing of kidney biopsy in type 2 diabetic patients: a stepwise approach
por: Hsieh, Jyh-Tong, et al.
Publicado: (2020)

Association of Hypoglycemia With Incident Chronic Kidney Disease in Patients With Type 2 Diabetes: A Nationwide Population-Based Study
por: Shih, Chia-Jen, et al.
Publicado: (2015)

Synbiotics Alleviate Hepatic Damage, Intestinal Injury and Muscular Beclin-1 Elevation in Rats after Chronic Ethanol Administration
por: Chen, Yi-Hsiu, et al.
Publicado: (2021)

Effect of add-on direct renin inhibitor aliskiren in patients with non-diabetes related chronic kidney disease
por: Li, Szu-yuan, et al.
Publicado: (2012)

Dipyridamole decreases dialysis risk and improves survival in patients with pre-dialysis advanced chronic kidney disease
por: Kuo, Ko-Lin, et al.
Publicado: (2017)

Indole produced during dysbiosis mediates host–microorganism chemical communication
por: Yang, Rui-Qiu, et al.
Publicado: (2023)

The Role of Gut Dysbiosis in the Bone–Vascular Axis in Chronic Kidney Disease
por: Evenepoel, Pieter, et al.
Publicado: (2020)

Chronic Kidney Disease, Gut Dysbiosis, and Constipation: A Burdensome Triplet
por: Ikee, Ryota, et al.
Publicado: (2020)

Association of Gut Microbiome Dysbiosis with Neurodegeneration: Can Gut Microbe-Modifying Diet Prevent or Alleviate the Symptoms of Neurodegenerative Diseases?
por: Tan, Li Yang, et al.
Publicado: (2021)

Artificial Intelligence for Risk Prediction of Rehospitalization with Acute Kidney Injury in Sepsis Survivors
por: Ou, Shuo-Ming, et al.
Publicado: (2022)

Evaluating the effects of a dietary synbiotic or synbiotic plus enhanced organic acid on broiler performance and cecal and carcass Salmonella load
por: Sobotik, Eric B., et al.
Publicado: (2021)

Dysbiosis of the gut microbiota in disease
por: Carding, Simon, et al.
Publicado: (2015)

In vitro Effects of Prebiotics and Synbiotics on Apis cerana Gut Microbiota
por: LV, MINGKUI, et al.
Publicado: (2021)

Sepsis and the Risks of Long-Term Renal Adverse Outcomes in Patients With Chronic Kidney Disease
por: Ou, Shuo-Ming, et al.
Publicado: (2022)

Synbiotics as Supplemental Therapy for the Alleviation of Chemotherapy-Associated Symptoms in Patients with Solid Tumours
por: Singh, Neeraj K., et al.
Publicado: (2023)

COVID-19 and gut dysbiosis, understanding the role of probiotic supplements in reversing gut dysbiosis and immunity
por: Aldhafiri, Fahad K.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iqlff7ogegrjvnlr63obs8f434